Ultraviolet phototoxicity of upconversion nanoparticles illuminated with near-infrared light
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ultraviolet phototoxicity of upconversion nanoparticles illuminated with near-infrared light
Authors
Keywords
-
Journal
Nanoscale
Volume 9, Issue 39, Pages 14921-14928
Publisher
Royal Society of Chemistry (RSC)
Online
2017-09-04
DOI
10.1039/c7nr04092j
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The influence of energy migration on luminescence kinetics parameters in upconversion nanoparticles
- (2016) Sergey Alyatkin et al. NANOTECHNOLOGY
- PEG-modified upconversion nanoparticles for in vivo optical imaging of tumors
- (2016) A. N. Generalova et al. RSC Advances
- Riboflavin photoactivation by upconversion nanoparticles for cancer treatment
- (2016) E. V. Khaydukov et al. Scientific Reports
- Light upconverting core–shell nanostructures: nanophotonic control for emerging applications
- (2015) Guanying Chen et al. CHEMICAL SOCIETY REVIEWS
- Cytotoxicity and non-specific cellular uptake of bare and surface-modified upconversion nanoparticles in human skin cells
- (2015) Anna E. Guller et al. Nano Research
- Submicron polyacrolein particles in situ embedded with upconversion nanoparticles for bioassay
- (2015) A. N. Generalova et al. Nanoscale
- In vivo 808 nm image-guided photodynamic therapy based on an upconversion theranostic nanoplatform
- (2015) Xiaomin Liu et al. Nanoscale
- Controlling upconversion nanocrystals for emerging applications
- (2015) Bo Zhou et al. Nature Nanotechnology
- A core-shell-shell nanoplatform upconverting near-infrared light at 808 nm for luminescence imaging and photodynamic therapy of cancer
- (2015) Fujin Ai et al. Scientific Reports
- PET imaging with multimodal upconversion nanoparticles
- (2014) Juan Gallo et al. DALTON TRANSACTIONS
- Lanthanide-doped upconversion nanoparticles electrostatically coupled with photosensitizers for near-infrared-triggered photodynamic therapy
- (2014) Meng Wang et al. Nanoscale
- One-Pot Solvothermal Synthesis of Highly Emissive, Sodium-Codoped, LaF3 and BaLaF5 Core-Shell Upconverting Nanocrystals
- (2014) Joshua Stecher et al. Nanomaterials
- Feasibility study of the optical imaging of a breast cancer lesion labeled with upconversion nanoparticle biocomplexes
- (2013) Ekaterina A. Grebenik et al. JOURNAL OF BIOMEDICAL OPTICS
- Upconversion Nanoparticles for Photodynamic Therapy and Other Cancer Therapeutics
- (2013) Chao Wang et al. Theranostics
- Designed Ankyrin Repeat Proteins (DARPins) as Novel Isoform-Specific Intracellular Inhibitors of c-Jun N-Terminal Kinases
- (2012) Petra Parizek et al. ACS Chemical Biology
- Covalently Assembled NIR Nanoplatform for Simultaneous Fluorescence Imaging and Photodynamic Therapy of Cancer Cells
- (2012) Kai Liu et al. ACS Nano
- Labeling of Anti-MUC-1 Binding Single Chain Fv Fragments to Surface Modified Upconversion Nanoparticles for an Initial in Vivo Molecular Imaging Proof of Principle Approach
- (2012) Anja Hischemöller et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- In vivo photodynamic therapy using upconversion nanoparticles as remote-controlled nanotransducers
- (2012) Niagara Muhammad Idris et al. NATURE MEDICINE
- Near-infrared light induced in vivo photodynamic therapy of cancer based on upconversion nanoparticles
- (2011) Chao Wang et al. BIOMATERIALS
- Photodynamic therapy of cancer: An update
- (2011) Patrizia Agostinis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- DARPins: An Efficient Targeting Domain for Lentiviral Vectors
- (2011) Robert C Münch et al. MOLECULAR THERAPY
- Wavelength-dependent penetration depths of ultraviolet radiation in human skin
- (2008) Merve Meinhardt et al. JOURNAL OF BIOMEDICAL OPTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started